South and Central America Cancer Vaccines Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Technology (Dendritic Cells Cancer Vaccines, Recombinant Cancer Vaccines, Antigen Cancer Vaccines, Whole Cell Cancer Vaccines, Viral Vector Cancer Vaccines); Type (Preventive Cancer Vaccines, Therapeutic Cancer Vaccines); Indication (Cervical Cancer, Prostate Cancer, Other Indications); End User (Pediatrics, Adults), and Country
Market Introduction
This research report provides insights into the South & Central AmericaCancer Vaccines market. The cancer vaccine is a vaccine which either treats existing cancer or prevents cancer from developing. Established cancer treatment vaccines are known as therapeutic cancer vaccines. Some / many of the vaccines are "autologous," are made from patient samples, and are unique to that patient. Additionally the cancer vaccines can be of two type, therapeutic vaccine and preventive vaccines. For instance, Cervarix, Gardasil, Gardasil-9 and Hepatitis B (HBV) vaccine (HEPLISAV-B) are Preventive Cancer Vaccines. Whereas, Bacillus Calmette-Guérin (BCG), Sipuleucel-T (Provenge) are Therapeutic Cancer Vaccines
Market Overview and Dynamics
The South and Central America cancer vaccines market was valued at US$ 191.89 million in 2019 and is projected to reach US$ 627.49 million by 2027; it is expected to grow at a CAGR of 16.3% during the forecast period.Factors driving demand growth include a rise in the prevalence of cancer worldwide and steps taken by South & Central Americaan health research organisations and major players in cancer vaccines. COVID19 has had a substantial effect on the industry due to delays in the supply chain and locking conditions. However, problems in the cancer vaccine industry, such as higher prices for cancer vaccines, impede market growth.
Key Market Segments
In terms of technology, the recombinant cancer vaccinessegment held the largest share of the market in 2019; and also is anticipated to register the highest CAGR in the market during the forecast period. In terms of type, the preventive cancer vaccine segment held a larger share of the market in 2019and also is estimated to register a higher market sharein the market during the forecast period. Likewise, in terms of end user, the pediatricssegment held a larger share of the market in 2019 and is estimated to register a higher CAGR in the market during the forecast period.
Major Sources and Companies Listed
The World Health Organization (WHO), Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), and Canadian MedTech Manufacturers’ Alliance are some of the major primary and secondary sources for the South & Central Americacancer vaccines market included in the report.
Reasons to buy the report
- To understand the South & Central Americacancer vaccinesmarket landscape and identifymarket segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for the South & Central Americacancer vaccines market
- Efficiently plan M&A and partnership dealsin the South & Central Americacancer vaccinesmarket by identifying market segments with the most promising probable sales
- Helps to takeknowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form the South & Central Americacancer vaccinesmarket
- Obtain market revenue forecast for market by various segments from 2019 to 2027 in the region
South & Central AmericaCancer vaccines Market Segmentation
By Technology
- Dendritic Cells Cancer Vaccines
- Recombinant Cancer Vaccines
- Antigen Cancer Vaccines
- Whole Cell Cancer Vaccines
- Viral Vector Cancer Vaccines
South & Central America Cancer Vaccines Market – By Type
- Preventive Cancer Vaccines
- Therapeutic Cancer Vaccine
South & Central America Cancer Vaccines Market – By Indication
- Cervical Cancer
- Prostate Cancer
- Other Indications
South & Central America Cancer Vaccines Market– By End Use
- Pediatrics
- Adults
Company Profiles
- AstraZeneca
- GlaxoSmithKline plc.
- Aduro Biotech Inc
- Pfizer Inc.
- Sanofi
- Bristol-Myers Squibb
- Moderna, Inc.
- OncBioMune Pharmaceuticals Inc.
- MaxiVAX
- Nouscom
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Central and South America Cancer Vaccines Market – By Technology
1.3.2 Central and South America Cancer Vaccines Market – By Type
1.3.3 Central and South America Cancer Vaccines Market – By Indication
1.3.4 Central and South America Cancer Vaccines Market– By End Use
1.3.5 Central and South America Cancer Vaccines Market– By Region
2. Cancer Vaccines Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Cancer Vaccines – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Expert Opinion
5. Central and South America Cancer Vaccines Market – Industry Dynamics
5.1 Key Drivers
5.1.1 Increase in Prevalence of Cancer Worldwide
5.1.2 Initiatives Taken by Global Health Research Organizations and Key Players for Cancer Vaccines
5.2 Key Market Restraints
5.2.1 Less Number of Commercially Available Vaccines for Treatment of Cancer
5.2.2 Higher Cost of Cancer Vaccines
5.3 Key Market Opportunities
5.3.1 Increasing Government support in Emerged Countries
5.4 Future Trends
5.4.1 Growing Research and Development Activities
5.5 Impact analysis
6. Cancer Vaccines Market – Regional Analysis
6.1 Central and South America Cancer Vaccines Market Revenue Forecast And Analysis
7. Central and South America Cancer Vaccines Market Analysis – By Technology
7.1 Overview
7.2 Cancer Vaccines Market Share, by Technology, 2019 and 2027 (%)
7.3 Dendritic Cells Cancer Vaccine
7.3.1 Overview
7.3.2 Dendritic Cells Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
7.5 Recombinant Cancer Vaccines
7.5.1 Overview
7.5.2 Recombinant Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
7.6 Antigen Cancer Vaccines
7.6.1 Overview
7.6.2 Antigen Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
7.7 Whole Cell Cancer Vaccines
7.7.1 Overview
7.7.2 Whole Cell Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
7.8 Viral Vector Cancer Vaccines
7.8.1 Overview
7.8.2 Viral Vector Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
8. Cancer Vaccines Market Analysis – By Type
8.1 Overview
8.2 Cancer Vaccines Market Revenue Share, by Type (2019 and 2027)
8.3 Preventive Cancer Vaccines
8.3.1 Overview
8.3.2 Preventive Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Therapeutic Cancer Vaccines
8.4.1 Overview
8.4.2 Therapeutic Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
9. Cancer Vaccines Market Analysis – By Indication
9.1 Overview
9.2 Cancer Vaccines Market Revenue Share, by Indication (2019 and 2027)
9.3 Cervical Cancer
9.3.1 Overview
9.3.2 Cervical Cancer: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
9.4 Prostate Cancer
9.4.1 Overview
9.4.2 Prostate Cancer: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
9.5 Other Indications
9.5.1 Overview
9.5.2 Other Indications: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
10. Cancer Vaccines Market Analysis – By End Use
10.1 Overview
10.2 Cancer Vaccines Market Revenue Share, by End Use (2019 and 2027)
10.3 Pediatrics
10.3.1 Overview
10.3.2 Pediatrics: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
10.4 Adults
10.4.1 Overview
10.4.2 Adults: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
11. Cancer Vaccines Market – Geographic Analysis
11.1 Central and South America: Cancer Vaccines Market
11.1.1 Overview
11.1.2 South and Central America: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)
11.1.3 South and Central America Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)
11.1.4 South and Central America Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)
11.1.5 South and Central America Cancer Vaccines Market, by Technology – Revenue and Forecast to 2027 (USD Million)
11.1.6 South and Central America Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)
11.1.7 South and Central America: Cancer Vaccines Market, by Country, 2019 & 2027 (%)
11.1.8 Brazil: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)
11.1.8.1 Brazil: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)
11.1.8.2 Brazil Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)
11.1.8.3 Brazil Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)
11.1.8.4 Brazil Cancer Vaccines Market, by Technology – Revenue and Forecast to 2027 (USD Million)
11.1.8.5 Brazil Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)
11.1.9 Argentina: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)
11.1.9.1 Argentina: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)
11.1.9.2 Argentina Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)
11.1.9.3 Argentina Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)
11.1.9.4 Argentina Cancer Vaccines Market, by Technology – Revenue and Forecast to 2027 (USD Million)
11.1.9.5 Argentina Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)
12. Impact Of COVID-19 Pandemic On Central and South America Cancer Vaccines Market
12.1 Central and South America: Impact Assessment of COVID-19 Pandemic
13. Cancer Vaccines Market – Industry Landscape
13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market, (%)
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview
14. Company Profiles
14.1 CSL Limited
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 ADURO BIOTECH INC.
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Astellas Pharma Inc.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Bristol-Myers Squibb Company
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 GlaxoSmithKline plc.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Dendreon
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 AstraZeneca
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Merck & Co., Inc.
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Sanofi (Sanofi Pasteur)
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 OSE Immunotherapeutics
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 Glossary of Terms
LIST OF TABLES
Table 1. South and Central America Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 2. South and Central America Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 3. South and Central America Cancer Vaccines Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 4. South and Central America Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 5. Brazil Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 6. Brazil Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 7. Brazil Cancer Vaccines Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 8. Brazil Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 9. Argentina Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 10. Argentina Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 11. Argentina Cancer Vaccines Market, by Technology- Revenue and Forecast to 2027 (USD Million)
Table 12. Argentina Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 13. Organic Developments Done By Companies
Table 14. Inorganic Developments Done By Companies
Table 15. Glossary of Terms, Cancer Vaccines Market
LIST OF FIGURES
Figure 1. Cancer Vaccines Market Segmentation
Figure 2. Cancer Vaccines Segmentation – By Region
Figure 3. Central and South America Cancer Vaccines Market Overview
Figure 4. In Recombinant Cancer Vaccines Segment Held Largest Share of Cancer Vaccines Market in 2019
Figure 5. Cancer Vaccines Market in US to Show Remarkable Growth During Forecast Period
Figure 7. Central and South America PEST Analysis
Figure 8. Cancer Statistics, 2020
Figure 9. Cancer Vaccines Market Impact Analysis of Driver and Restraints
Figure 10. Central and South America Cancer Vaccines Market – Revenue Forecast And Analysis – 2019- 2027
Figure 11. Cancer Vaccines market Share, by Technology, 2019 and 2027 (%)
Figure 12. Dendritic Cells Cancer Vaccines : Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 13. Recombinant Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 14. Antigen Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 15. Whole Cell Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 16. Viral Vector Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 17. Cancer Vaccines Market Revenue Share, by Type (2019 and 2027)
Figure 18. Preventive Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 19. Therapeutic Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 20. Cancer Vaccines Market Revenue Share, by Indication (2019 and 2027)
Figure 21. Cervical Cancer: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 22. Prostate Cancer: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 23. Other Indications: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 24. Cancer Vaccines Market Revenue Share, by End Use (2019 and 2027)
Figure 25. Pediatrics: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 26. Adults: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 27. Central and South America: Cancer Vaccines Market, by Key Country – Revenue (2019) (USD Million)
Figure 28. Central and South America Cancer Vaccines Market Revenue and Forecast to 2027 (USD Million)
Figure 29. Central and South America: Cancer Vaccines Market, by Country, 2019 & 2027 (%)
Figure 30. Brazil: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)
Figure 31. UK: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)
Figure 32. France: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)
Figure 33. Spain: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)
Figure 34. Italy: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)
Figure 35. Impact of COVID-19 Pandemic in Central and South America Country Markets
Figure 36. Growth Strategies Done by the Companies in the Market, (%)
The List of Companies - South and Central America Cancer Vaccines Market
- AstraZeneca
- GlaxoSmithKline plc.
- Aduro Biotech Inc
- Pfizer Inc.
- Sanofi
- Bristol-Myers Squibb
- Moderna, Inc.
- OncBioMune Pharmaceuticals Inc.
- MaxiVAX
- Nouscom
- To understand the South & Central America cancer vaccines market landscape and identify market segments that are most likely to guarantee a strong return.
- Stay ahead of the race by comprehending the ever-changing competitive landscape for the South & Central America cancer vaccines market.
- Efficiently plan M&A and partnership dealsin the South & Central America cancer vaccines market by identifying market segments with the most promising probable sales.
- Helps to takeknowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form the South & Central Americacancer vaccines market.
- Obtain market revenue forecast for market by various segments from 2019 to 2027 in the region